Product NDC: | 64764-158 |
Proprietary Name: | Actoplus Met |
Non Proprietary Name: | pioglitazone and metformin hydrochloride |
Active Ingredient(s): | 850; 15 mg/1; mg/1 & nbsp; pioglitazone and metformin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64764-158 |
Labeler Name: | Takeda Pharmaceuticals America, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021842 |
Marketing Category: | NDA |
Start Marketing Date: | 20050829 |
Package NDC: | 64764-158-41 |
Package Description: | 4 CARTON in 1 TRAY (64764-158-41) > 1 BLISTER PACK in 1 CARTON > 7 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 64764-158-41 |
Proprietary Name | Actoplus Met |
Package Description | 4 CARTON in 1 TRAY (64764-158-41) > 1 BLISTER PACK in 1 CARTON > 7 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 64764-158 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pioglitazone and metformin hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20050829 |
Marketing Category Name | NDA |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
Strength Number | 850; 15 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |